4.7 Article

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C

Related references

Note: Only part of the references are listed.
News Item Biotechnology & Applied Microbiology

Landmark approval for Dendreon's cancer vaccine

Laura DeFrancesco

NATURE BIOTECHNOLOGY (2010)

Article Medicine, General & Internal

Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer

Scott A. Waldman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Oncology

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity

Adam E. Snook et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Review Immunology

It is the antigen(s), stupid and other lessons from over a decade of vaccitherapy of human cancer

Matthew R. Buckwalter et al.

SEMINARS IN IMMUNOLOGY (2008)

Article Pharmacology & Pharmacy

Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen

A. E. Snook et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Medicine, General & Internal

Effector memory T cells, early metastasis, and survival in colorectal cancer

F Pagès et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Gastroenterology & Hepatology

Colorectal cancer vaccines: Principles, results, and perspectives

S Mocellin et al.

GASTROENTEROLOGY (2004)

Article Biochemistry & Molecular Biology

T-cell response to adenovirus hexon and DNA-binding protein in mice

T McKelvey et al.

GENE THERAPY (2004)

Article Multidisciplinary Sciences

Projection of an immunological self shadow within the thymus by the aire protein

MS Anderson et al.

SCIENCE (2002)

Review Oncology

The role of CD8+ T cells in immune responses to colorectal cancer

LV Titu et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)